Novel insights in ICU-acquired respiratory muscle dysfunction: implications for clinical care

Annemijn H Jonkman; Diana Jansen; Leo M A Heunks

doi:10.1186/s13054-017-1642-0

Novel insights in ICU-acquired respiratory muscle dysfunction: implications for clinical care

Crit Care. 2017 Mar 21;21(1):64. doi: 10.1186/s13054-017-1642-0.

Authors

Annemijn H Jonkman¹, Diana Jansen², Leo M A Heunks³

Affiliations

¹ VU University Medical Center, Department of Intensive Care Medicine, 1007 MB, Amsterdam, Netherlands.
² Radboudumc, Department of Anesthesiology, Nijmegen, Netherlands.
³ VU University Medical Center, Department of Intensive Care Medicine, 1007 MB, Amsterdam, Netherlands. [email protected].

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency medicine 2017. Other selected articles can be found online at http://ccforum.com/series/annualupdate2017 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901 .

Publication types

Review

MeSH terms

Airway Management / adverse effects*
Cardiotonic Agents / pharmacology
Cardiotonic Agents / therapeutic use
Humans
Hydrazones / pharmacology
Hydrazones / therapeutic use
Intensive Care Units / organization & administration
Length of Stay / statistics & numerical data*
Muscular Atrophy / etiology
Pyridazines / pharmacology
Pyridazines / therapeutic use
Respiratory Muscles / drug effects
Respiratory Muscles / metabolism*
Respiratory Muscles / physiopathology
Simendan
Testosterone Congeners / pharmacology
Testosterone Congeners / therapeutic use

Substances

Cardiotonic Agents
Hydrazones
Pyridazines
Testosterone Congeners
Simendan